Tanvex BioPharma Market Cap

Tanvex BioPharma has a market cap or net worth of 11.19 billion as of March 9, 2026. Its market cap has decreased by -28.38% in one year.

Market Cap

11.19B

Enterprise Value

11.34B

Revenue

224.83M

Ranking

n/a

PE Ratio

n/a

Stock Price

42.50

Market Cap Chart

Since August 13, 2015, Tanvex BioPharma's market cap has decreased from 16.77B to 11.19B, a decrease of -33.28%. That is a compound annual growth rate of -3.75%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	11.19B	-23.18%
Dec 31, 2025	14.56B	36.15%
Dec 31, 2024	10.70B	22.75%
Dec 29, 2023	8.71B	-29.59%
Dec 30, 2022	12.38B	-39.56%
Dec 30, 2021	20.48B	106.96%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Medigen Vaccine Biologics	12.10B
Ever Supreme Bio Technology	12.66B
TCM Biotech International	14.02B
Gongwin Biopharm Holdings	9.81B
AP Biosciences	14.46B
TaiMed Biologics	14.62B
PharmaEngine	8.78B
TaiGen Biopharmaceuticals Holdings	8.68B

Market Cap Rankings